Maprotiline

CHEMBL21731 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

277.4 g/mol

LogP

4.6

Phase

4

A tetracyclic antidepressant that works by blocking the reuptake of norepinephrine in the brain, used to treat major depressive disorder and anxiety associated with depression. It takes several weeks of regular use to achieve its full therapeutic effect.

Masse moléculaire

277,4000 g/mol

LogP

4,60

TPSA

12,00 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Schizophrenia Generalized Anxiety Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CNCCCC12CCC(c3ccccc31)c1ccccc12

InChI

InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3

Molecular Formula

C20H23N

HBD / HBA

1 / 1

Liaisons Rotatives

4

Atomes Lourds

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A tetracyclic antidepressant that works by blocking the reuptake of norepinephrine in the brain, used to treat major depressive disorder and anxiety associated with depression. It takes several weeks of regular use to achieve its full therapeutic effect.

Yes, Maprotiline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL21731. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4011. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Maprotiline sur PillFYI

Structure

Données Clés

Formule: C20H23N

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.